Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China · Delayed Price · Currency is CNY 14.90
+0.48 (3.33%)
Sep 30, 2026, 3:04 PM CST
SHE:002907 Revenue
Chongqing Pharscin Pharmaceutical had revenue of 201.70M CNY in the quarter ending June 30, 2026, a decrease of -0.62%. This brings the company's revenue in the last twelve months to 798.78M, down -0.01% year-over-year. In the year 2025, Chongqing Pharscin Pharmaceutical had annual revenue of 827.14M with 6.75% growth.
Revenue (ttm)
798.78M
Revenue Growth
-0.01%
P/S Ratio
7.79
Revenue / Employee
n/a
Employees
1,439
Market Cap
6.22B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 827.14M | 52.32M | 6.75% |
| Dec 31, 2024 | 774.82M | 83.28M | 12.04% |
| Dec 31, 2023 | 691.54M | -93.64M | -11.93% |
| Jan 1, 2023 | 785.18M | -60.96M | -7.20% |
| Jan 1, 2022 | 846.14M | -36.33M | -4.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KPC Pharmaceuticals,Inc. | 4.87B |
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.73B |
| Cisen Pharmaceutical | 3.40B |
| Guizhou Bailing Group Pharmaceutical | 2.56B |
| Sunflower Pharmaceutical Group | 2.51B |
| Bide Pharmatech | 1.38B |
| Hunan Er-Kang Pharmaceutical | 1.05B |
| Hainan Haiyao | 702.17M |